CSI Singapore

CSI Singapore To better understand the causes of human cancer across Asia, thereby improve its detection, treatment and prevention.

We are delighted to share that Dr. Dennis Kappei has been awarded the Singapore Therapeutics Development Review (STDR) p...
20/11/2025

We are delighted to share that Dr. Dennis Kappei has been awarded the Singapore Therapeutics Development Review (STDR) pre-pilot grant under the RIE 2025 Human Health & Potential (HHP) Industry Alignment Fund Pre-Positioning (IAF-PP)! He is the lead principal investigator, with Dr. Anand D Jeyasekharan serving as a co-investigator for the project titled 'Give me a break - selectively targeting ALT-positive sarcomas'. 🎉

Interested in pursuing a PhD in Cancer Biology?The CSI Graduate Program gives you the training, mentorship, and full sup...
19/11/2025

Interested in pursuing a PhD in Cancer Biology?
The CSI Graduate Program gives you the training, mentorship, and full support you need to make real impact — from premium scholarships to hands-on lab experience.
Join us and take the next step in advancing your growth as a cancer researcher!

Celebrating excellence in research! 🎉Congratulations to Dr. Qing Yun Tong for winning the Best Poster Award at the Asia ...
18/11/2025

Celebrating excellence in research! 🎉

Congratulations to Dr. Qing Yun Tong for winning the Best Poster Award at the Asia RNA Club Symposium 2025 for his poster titled 'Mapping the RNA-binding Protein Landscape in Colorectal Cancer'. 👏🧬


Earlier today, CSI Singapore, together with Institute of Molecular and Cell Biology (IMCB) Agency for Science, Technolo...
17/11/2025

Earlier today, CSI Singapore, together with Institute of Molecular and Cell Biology (IMCB) Agency for Science, Technology and Research (A*STAR), hosted Prof. Hans-Guido Wendel from Memorial Sloan Kettering Cancer Center on Zoom. He spoke on the topic “Turning Cancer's Strengths into Targetable Liabilities”.

CSI Singapore would like to welcome onboard our new PI, Prof. Gopal Iyer to the CSI community. 👏 His research focus is o...
14/11/2025

CSI Singapore would like to welcome onboard our new PI, Prof. Gopal Iyer to the CSI community. 👏 His research focus is on the discovery of new biomarkers & therapeutic targets to improve precision therapy for head & neck cancers.

Read more about him: https://csi.nus.edu.sg/researcher/narayanan-gopalakrishna-iyer/

🌟 Frontiers in Cancer Science 2025: A Wonderful ConclusionFrontiers in Cancer Science 2025 concluded after an intense we...
13/11/2025

🌟 Frontiers in Cancer Science 2025: A Wonderful Conclusion

Frontiers in Cancer Science 2025 concluded after an intense week of scientific discussion and exchange of knowledge and ideas. We extend our heartfelt appreciation to all speakers, session chairs, abstract presenters, and delegates for making this year’s conference a resounding success. Your energy and insights continue to drive progress in cancer research and discovery.

Special appreciation also goes to our organizing committee members, as well as our conference partner, the American Association for Cancer Research; media partner Asia Research News and other generous sponsors for their invaluable support in bringing the cancer science community together once again.

🎉 Congratulations to our Poster Presentation Winners!

This year, four outstanding presentations were recognized, with the top 2 - Rui Xue Lee and Rong En Tay - tying for first place, each receiving a Travel Award to AACR 2026! The third- and fourth-place winners, Yun Suen Kho and Wan Ting Kong received generous Amazon e-gift cards.

Your creativity, rigor, and dedication exemplify the spirit of FCS.

Congratulations to all presenters for showcasing world-class research!

We look forward to seeing you next November at Frontiers in Cancer Science 2026!

🎉 Congratulations to the Lightning Talk Speakers of FCS 2025!We’re proud to celebrate ten researchers whose work advance...
06/11/2025

🎉 Congratulations to the Lightning Talk Speakers of FCS 2025!
We’re proud to celebrate ten researchers whose work advances the understanding and treatment of cancer.
Join us in applauding their achievements at , 5–7 November in Singapore!

🏅 Dr Allison Chan – Cancer Science Institute of Singapore, Singapore
"Aggressive B-cell Lymphomas Retain ATR-Dependent Determinants of T-cell Exclusion from the Germinal Center Dark Zone"
🏅 Dr Corrine Ying Xu Chua – Houston Methodist Research Institute
“Sustained Intratumoral Delivery Transforms a Systemically Lethal Immunotherapy Combination into a Safe and Curative Treatment”
🏅 Dr Komal Gupta – National Cancer Centre Singapore
"How EGFR Mutations Shape Lung Cancer in Never-Smokers"
🏅 Dr Michal Marek Hoppe –Singapore Translational Cancer Consortium (STCC)
"Spatial Phenotypes Ascribed to Cancers with Extreme Resistance (SPACER) in HR+ HER2- Metastatic Breast Cancer – a Multi-Institutional Use-Case Study of the Translational Research Integration and Support Platform by the Singapore Translational Cancer Consortium (STCC)"
🏅 Ankit Jana - National University of Singapore
"Epigenetic Vulnerabilities Drive Survival of Drug-Tolerant Persisters and Reveal Therapeutic Opportunities in AML"
🏅 Xiao Jing Ong – Peter MacCallum Cancer Centre
“Targeting T-cell Lymphomas with CAR-T Cell Therapy: Overcoming Safety, Antigen Escape, and Manufacturing Barriers”
🏅 Yating Shen – National University of Singapore
"Dual Inhibition of Protein Degradation and Nuclear Export Uncovers Molecular Dependencies in Gliomas"
🏅 Madelaine Theardy – Harvard University
“Therapeutic Targeting of Syndecan-1 Axis Overcomes Acquired Resistance to KRAS-Targeted Therapy in Gastrointestinal Cancers”
🏅Shobha VASUDEVAN • Senior Principal Scientist II; Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR)
"Targeting Post-transcriptional Mechanisms of Tumour Persistence"
🏅 Dr Shu Zhang – Stanford University
“EcDNA-borne PVT1 Fusions Stabilize Transcripts and Enhance MYC Oncogenic Functions”
https://csi.nus.edu.sg/fcs/

We’re live at the 📌 NUS University Cultural Centre for the Frontiers in Cancer Science Conference 2025! 🌟 3 days of ins...
05/11/2025

We’re live at the 📌 NUS University Cultural Centre for the Frontiers in Cancer Science Conference 2025! 🌟

3 days of inspiring talks, cutting-edge discoveries, and collaboration begins — all united by one goal: advancing the frontiers of cancer research.

It's not too late to attend! Come by to register on-site or via the link: https://csi.nus.edu.sg/fcs/

Keep updated on real-time photos and videos of the conference activities on CSI Singapore's Instagram Stories.

We’re live at the 📌 NUS University Cultural Centre for the Frontiers in Cancer Science Conference 2025! 🌟 3 days of insp...
05/11/2025

We’re live at the 📌 NUS University Cultural Centre for the Frontiers in Cancer Science Conference 2025! 🌟

3 days of inspiring talks, cutting-edge discoveries, and collaboration begins — all united by one goal: advancing the frontiers of cancer research.

It's not too late to attend! Come by to register on-site or via the link: https://csi.nus.edu.sg/fcs/

Keep updated on real-time photos and videos of the conference activities on CSI Singapore's Instagram Stories.

oncology

🎉 Congratulations to our Frontiers in Cancer Science 2025 Outstanding Abstract Travel Award Winners!We’re proud to celeb...
05/11/2025

🎉 Congratulations to our Frontiers in Cancer Science 2025 Outstanding Abstract Travel Award Winners!

We’re proud to celebrate ten exceptional early-career researchers whose work advances the understanding and treatment of cancer.
Join us in applauding their achievements and welcoming them to , 5–7 November 2025 in Singapore!

🏅 Dr Corrine Ying Xu Chua – Houston Methodist Research Institute
“Sustained Intratumoral Delivery Transforms a Systemically Lethal Immunotherapy Combination into a Safe and Curative Treatment”

🏅 Kimberly Meza – Brown University
“PIM inhibition potentiates TRAIL apoptosis in renal cell carcinoma”

🏅 Xiao Jing Ong – Peter MacCallum Cancer Centre
“Targeting T-cell Lymphomas with CAR-T Cell Therapy: Overcoming Safety, Antigen Escape, and Manufacturing Barriers”

🏅 Suphong Plangsothorn – Chulalongkorn University
“Decoding the Lung Cancer Acetylome: Epigenetic Signatures and Prognostic Implications”

🏅 Kansate Prasertsuk – Chulalongkorn University
“Integrative Transcriptomic and Deep Learning Model Identifies Anti-Cancer Peptides Targeting KIF2C in Breast Cancer”

🏅 Agustina Sabater – The University of Texas MD Anderson Cancer Center + University of Buenos Aires
“FGFR Inhibitor, Erdafitinib, Reshapes Prostate Cancer Skeletal Metastases via Modulation of Cancer-Stemness and Tumor-Bone Interface”

🏅 Madelaine Theardy – Harvard University
“Therapeutic Targeting of Syndecan-1 Axis Overcomes Acquired Resistance to KRAS-Targeted Therapy in Gastrointestinal Cancers”

🏅 Lucas Ueta – University of California, Irvine
“Transposable Element Patterns Across Genetic Ancestries in Prostate Cancer Patients”

🏅 Arun Viswanathan – Rajiv Gandhi Centre for Biotechnology
“STAT3-Mediated Immune Dysfunction And BMI-Stratified Therapeutic Windows in Obesity-Associated Pancreatic Cancer”

🏅 Dr Shu Zhang – Stanford University
“EcDNA-borne PVT1 Fusions Stabilize Transcripts and Enhance MYC Oncogenic Functions”

https://csi.nus.edu.sg/fcs/

Last week, CSI Singapore hosted Dr. Simon Boulton from The Francis Crick Institute. He spoke on the topic “Exploiting th...
03/11/2025

Last week, CSI Singapore hosted Dr. Simon Boulton from The Francis Crick Institute. He spoke on the topic “Exploiting the ‘End Replication Problem’ in Cancer”.

Address

14 Medical Drive, Centre For Translational Medicine, #12/01
Singapore
117599

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+6565165394

Website

Alerts

Be the first to know and let us send you an email when CSI Singapore posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category